Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB.
Rich M, Socci A, Mitnick C, Nardell E, Becerra M, Bonilla C, Bayona J, Seung K, Furin J, Farmer P, Mukherjee J. Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB. The International Journal Of Tuberculosis And Lung Disease 2006, 10: 290-6. PMID: 16562709.Peer-Reviewed Original ResearchConceptsPrevious treatment exposureRetreatment regimensDrug susceptibility testingPatient populationDST patternsTreatment exposureGroup 1Likely effective drugsMDR-TB regimensSecond-line drugsDrug susceptibility patternsNational Tuberculosis ProgrammeDifferent patient populationsAnti-tuberculosis agentsIndividualized regimensMDR-TBTuberculosis ProgrammeEffective anti-tuberculosis agentsSusceptibility patternsDST resultsRegimensEffective drugsPatientsGroup 4Susceptibility testing